Peikin Mark Howard 13D/13G Filings for Adial Pharmaceuticals, Inc. (ADIL)

Peikin Mark Howard 13D and 13G filings for Adial Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-14
5:24 pm
Sale
2022-02-14 13G Adial Pharmaceuticals, Inc.
ADIL
Peikin Mark Howard 36,178
4.400%
-17,692decrease
(-32.84%)
Filing
2021-08-18
06:03 am
Purchase
2021-08-17 13G Adial Pharmaceuticals, Inc.
ADIL
Peikin Mark Howard 53,870
6.670%
9,060increase
(+20.22%)
Filing
2021-08-13
06:01 am
Purchase
2021-08-03 13G Adial Pharmaceuticals, Inc.
ADIL
Peikin Mark Howard 44,810
5.520%
44,810increase
(New Position)
Filing